Predictors of Residual Invasive Disease after Core Needle Biopsy Diagnosis of Ductal Carcinoma In Situ
Author:
Publisher
Hindawi Limited
Subject
Oncology,Surgery,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1524-4741.2007.00418.x/fullpdf
Reference37 articles.
1. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia.
2. A core breast biopsy diagnosis of invasive carcinoma allows for definitive surgical treatment planning
3. Image-Guided Core-Needle Breast Biopsy Is an Accurate Technique to Evaluate Patients With Nonpalpable Imaging Abnormalities
4. Nondiagnostic stereotaxic core breast biopsy: results of rebiopsy.
5. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy.
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Radiological and pathological predictors of post-operative upstaging of breast ductal carcinoma in situ (DCIS) to invasive ductal carcinoma and lymph-nodes metastasis; a potential algorithm for node surgical de-escalation;Surgical Oncology;2024-10
2. Radiological and Pathological Predictors of Post-Operative Upstaging of Breast Ductal Carcinoma in Situ (Dcis) to Invasive Ductal Carcinoma and Lymph-Nodes Metastasis; a Potential Algorithm for Node Surgical De-Escalation;2023
3. Oncological Safety of Skin-Sparing Mastectomy and Immediate Breast Reconstruction in Extensive Ductal Carcinoma In Situ;Journal of Surgical Research;2022-11
4. Influence of rurality on lymph node assessment among women diagnosed with ductal carcinoma in situ and treated with mastectomy, SEER 2000–2015;Breast Cancer Research and Treatment;2022-01-24
5. High EZH2 expression in ductal carcinoma in situ diagnosed on breast core needle biopsy is an independent predictive factor for upgrade on surgical excision;Pathology - Research and Practice;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3